Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Return on Assets (2022 - 2025)

Taysha Gene Therapies' Return on Assets history spans 4 years, with the latest figure at 0.29% for Q3 2025.

  • For Q3 2025, Return on Assets rose 14.0% year-over-year to 0.29%; the TTM value through Sep 2025 reached 0.29%, up 14.0%, while the annual FY2024 figure was 0.51%, 1.0% down from the prior year.
  • Return on Assets for Q3 2025 was 0.29% at Taysha Gene Therapies, up from 0.37% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.29% in Q3 2025 and bottomed at 1.4% in Q4 2022.
  • The 4-year median for Return on Assets is 0.49% (2024), against an average of 0.68%.
  • The largest annual shift saw Return on Assets soared 100bps in 2023 before it fell -10bps in 2024.
  • A 4-year view of Return on Assets shows it stood at 1.4% in 2022, then skyrocketed by 71bps to 0.4% in 2023, then dropped by -24bps to 0.5% in 2024, then skyrocketed by 42bps to 0.29% in 2025.
  • Per Business Quant, the three most recent readings for TSHA's Return on Assets are 0.29% (Q3 2025), 0.37% (Q2 2025), and 0.55% (Q1 2025).